Publication Cover
Orbit
The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery
Volume 38, 2019 - Issue 5
112
Views
4
CrossRef citations to date
0
Altmetric
Case Report

Recurrent natural killer/T-cell lymphoma of the lacrimal sac and nasolacrimal duct in a 59-year-old Caucasian woman

, , &
Pages 428-431 | Received 31 Aug 2018, Accepted 07 Nov 2018, Published online: 05 Dec 2018

References

  • Tse E, Kwong YL. The diagnosis and management of NK/T-cell lymphomas. J Hematol Oncol. 2017;10(1):85. doi:10.1186/s13045-017-0452-9.
  • Kwong YL. The diagnosis and management of extranodal NK/T-cell lymphoma, nasal-type and aggressive NK-cell leukemia. J Clin Exp Hematop. 2011;51(1):21–28. doi:10.3960/jslrt.51.21.
  • Batsakis JG, Luna MA. Midfacial necrotizing lesions. Semin Diagn Pathol. 1987;4:90–116.
  • Jakobiec FA. Ocular adnexal lymphoid tumors: progress in need of clarification. Am J Ophthalmol. 2008;145(6):941–950. doi:10.1016/j.ajo.2008.03.013.
  • Ferry JA, Fung CY, Zukerberg L, et al. Lymphoma of the ocular adnexa: a study of 353 cases. Am J Surg Pathol. 2007;31(2):170–184. doi:10.1097/01.pas.0000213350.49767.46.
  • Coupland SE, Krause L, Delecluse HJ, et al. Lymphoproliferative lesions of the ocular adnexa: analysis of 112 cases. Ophthalmology. 1998;105(8):1430–1441. doi:10.1016/S0161-6420(98)98024-1.
  • Mikhail M, Michel RP, Chankowsky J, Arthurs B. Epiphora as first presenting sign of primary extranodal NK/T-cell lymphoma of the lacrimal sac. Orbit. 2017;36(1):19–21. doi:10.1080/01676830.2017.1279649.
  • Mori T, Tokuhira M, Mori S, et al. Primary natural killer cell lymphoma of the lacrimal sac. Ann Hematol. 2001;80(10):607–610. doi:10.1007/s002770100368.
  • Woog JJ, Kim YD, Yeatts RP, et al. Natural killer/T-cell lymphoma with ocular and adnexal involvement. Ophthalmology. 2006;113(1):140–147. doi:10.1016/j.ophtha.2005.09.036.
  • Shi J, Tu Y, Combined External WW. Endoscopic, endonasal-assisted en bloc resection of malignant tumors from the lacrimal drainage system. J Craniofac Surg. 2018;1. doi:10.1097/scs.0000000000004655.
  • Kim JW, An JH. Extranodal natural killer/T-cell lymphoma, nasal type, of the orbit mimicking recurrent orbital cellulitis. J Craniofac Surg. 2014;25(2):509–511. doi:10.1097/scs.0000000000000677.
  • Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 2006;107(1):265–276. doi:10.1182/blood-2005-06-2508.
  • Perry AM, Diebold J, Nathwani BN, et al. Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the international non-Hodgkin lymphoma classification project. Haematologica. 2016;101(10):1244–1250. doi:10.3324/haematol.2016.148809.
  • Yamaguchi M. Treatment of NK/T-cell lymphoma: current situations and prospectives. Rinsho Ketsueki. 2018;59(5):588–593. doi:10.11406/rinketsu.59.588.
  • Song X, Wang J, Wang S, Wang W, Wang S, Zhu W. Clinical analysis of 90 cases of malignant lacrimal sac tumor. Graefes Arch Clin Exp Ophthalmol. 2018;256(7):1333–1338. doi:10.1007/s00417-018-3962-4.
  • Gungor A, Pennington L, Sankararaman S, Zaid-Kaylani S, Jeroudi MA. A 14-year-old boy with extranodal natural killer cell lymphoma of the nose, nasopharynx, larynx, and trachea in remission 6 years after primary diagnosis. A longitudinal case report. Am J Otolaryngol. 2016;37(6):563–566. doi:10.1016/j.amjoto.2016.08.004.
  • Watanabe K, Hanamura A, Mori N. A unique case of nasal NK/T cell lymphoma with frequent remission and relapse showing different histological features during 12 years of follow up. J Clin Exp Hematop. 2010;50(1):65–69. doi:10.3960/jslrt.50.65.
  • Li X, Cui Y, Sun Z, et al. DDGP versus SMILE in newly diagnosed advanced natural killer/T-Cell lymphoma: a randomized controlled, multicenter, open-label study in China. Clin Cancer Res. 2016;22(21):5223–5228. doi:10.1158/1078-0432.ccr-16-0153.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.